Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Updated: FAQ on New SEC Rules on Exhibit Hyperlinks – Exhibit Indexes

Securities Law Exchange Blog

Publications

September 12, 2017

Now that the SEC's new rules on exhibit hyperlinks are live as of September 1, 2017, we have updated our March blog post with the frequently asked question below regarding exhibit indexes.

Where should we put the exhibit index now? Can we combine the list of exhibits and the exhibit index?

In connection with the SEC's March 2017 amendments implementing the hyperlink requirement, the SEC also amended the rules pertaining to placement of exhibit index, which had previously required the exhibit index to "precede immediately the exhibits filed with such registration statement." As amended, Rule 102(d) of Regulation S-T and Rule 601(a)(2) of Regulation S-K now require the exhibit index to "appear before the required signatures in the registrant statement or report." Although exhibit index practice has varied, there is some ambiguity as to whether the new rules require a separate exhibit index before the signature page and the exhibits themselves. For example, while some companies are combining the exhibit table with the exhibit index and placing the latter before the signature page, others have been retaining a separate exhibit table and exhibit index and move the latter above the signatures.

As a result of this ambiguity and variance in practice, we reached out to the SEC staff to get interpretive guidance on how the list of exhibits (including the exhibit index) should now be presented in registration statements and reports. According to the SEC Staff in the Office of Chief Counsel, it is permissible to combine the exhibit table with the exhibit index and only present one list of exhibits with hyperlinks, and a separate exhibit index is not required. In fact, he said the purpose of the rule was to make presentation simpler, and presenting only one exhibit list above the signatures (like described in option 2 below) may be preferable in this regard. I think this is a good, practicable outcome and should dispense with the notion of having two lists of exhibits.

Click here to view an example of the approach applied on an 8-K.

If you have other questions about the SEC rules on exhibit hyperlinks, please contact me or another member of our Corporate & Securities Practice Group.

Securities Law Exchange Blog

Bass, Berry & Sims' Securities Law Exchange blog features commentary and practical insight on SEC updates for publicly traded companies.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.